Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc.（CGEM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cgem · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$37.00
Consensus
$31.00
+134.8% upside
Low
$28.00
Median: $30 · Last Close: $13.21
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$31.00
134.8% upside
High Target
$37
180.2%
Low Target
$28
112.0%
Current Price
$13.21
as of today
Based on analyst price targets, the CGEM stock price prediction for the next 12 months ranges from $28 to $37. The consensus CGEM price forecast of $31.00 implies 134.8% upside from the current price of $13.21.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.79 | ↓ 3.17% |
1-day model range: $12.67–$12.9. Peak: $12.9 (-3.17%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $10 | -24.9% |
| 2028 | $9 | -35.2% |
| 2029 | $8 | -40.1% |
| 2030 | $8 | -42.6% |
| 2031 | — | -43.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CGEM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | BTIG | Maintains | Buy→Buy |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-04 | BTIG | Maintains | Buy→Buy |
| 2026-04-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-28 | BTIG | Maintains | Buy→Buy |
| 2026-03-11 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-09 | Wedbush | Maintains | Outperform→Outperform |
| 2025-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cullinan Therapeutics, Inc. (CGEM) stock. Of the recent 43 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover CGEM.
分析师推荐趋势
CGEM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$20M
↓ 37.4% YoY
Revenue Next Year
$48M
↑ 142.4% YoY
EPS This Year
$-3.06
EPS Next Year
$-2.43
↓ 20.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast CGEM EPS of $-3.06 for the current fiscal year, based on estimates from 8 analysts. The CGEM revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CGEM 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CGEM 的共识目标价为 $31.00（+134.8% 上行空间），分析师共识为 Buy。
CGEM 的短期预测（明日）为 $12.79（-3.17%）。 CGEM 对 2027 年的股价预测均值为 $10。 CGEM 对 2030 年的预测区间为 $7–$8。
Cullinan Therapeutics, Inc. 在 NASDAQ 上市，代码 CGEM。CGEM 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CGEM 预测 · 8 个问题根据 8 位华尔街分析师，CGEM 的 12 个月平均目标价为 $31.00，最高 $37.00、最低 $28.00。若有图表，中位目标价可在上方查看。相对当前价 $13.21，隐含约 +134.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.